Zur Rose Group AG
DocMorris AG operates as an online pharmacy, telemedicine, and healthcare company in Switzerland and internationally. It offers prescription and over-the-counter medicines, and consumer health products, as well as beauty and personal care products, nutritional supplements, painkillers, and first aid products. The company also provides professional health care services to doctors, pharmacies, insu… Read more
Zur Rose Group AG (ZRSEF) - Total Assets
Latest total assets as of June 2025: $907.44 Million USD
Based on the latest financial reports, Zur Rose Group AG (ZRSEF) holds total assets worth $907.44 Million USD as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Zur Rose Group AG - Total Assets Trend (2009–2024)
This chart illustrates how Zur Rose Group AG’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Zur Rose Group AG - Asset Composition Analysis
Current Asset Composition (December 2024)
Zur Rose Group AG's total assets of $907.44 Million consist of 27.5% current assets and 72.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 12.3% |
| Accounts Receivable | $69.84 Million | 9.0% |
| Inventory | $37.08 Million | 4.8% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $129.78 Million | 16.7% |
| Goodwill | $364.78 Million | 46.9% |
Asset Composition Trend (2009–2024)
This chart illustrates how Zur Rose Group AG's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zur Rose Group AG's current assets represent 27.5% of total assets in 2024, a decrease from 61.5% in 2009.
- Cash Position: Cash and equivalents constituted 12.3% of total assets in 2024, up from 10.3% in 2009.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 62.0% of total assets, an increase from 28.0% in 2009.
- Asset Diversification: The largest asset category is goodwill at 46.9% of total assets.
Zur Rose Group AG Competitors by Total Assets
Key competitors of Zur Rose Group AG based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cachet Pharmaceutical Co Ltd
SHE:002462
|
China | CN¥12.68 Billion |
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.84 Billion |
|
Luyan Pharma Co Ltd
SHE:002788
|
China | CN¥13.04 Billion |
|
Ji Yao Holding Group Co Ltd
SHE:300108
|
China | CN¥1.43 Billion |
|
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
SHE:300937
|
China | CN¥1.75 Billion |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
China | CN¥9.84 Billion |
|
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
SHE:301126
|
China | CN¥6.56 Billion |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
China | CN¥5.26 Billion |
Zur Rose Group AG - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Zur Rose Group AG generates 1.31x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Zur Rose Group AG is currently not profitable relative to its asset base.
Zur Rose Group AG - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.25 | 1.75 | 2.89 |
| Quick Ratio | 2.85 | 1.52 | 2.31 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $245.21 Million | $ 142.50 Million | $ 342.43 Million |
Zur Rose Group AG - Advanced Valuation Insights
This section examines the relationship between Zur Rose Group AG's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.83 |
| Latest Market Cap to Assets Ratio | 0.64 |
| Asset Growth Rate (YoY) | -10.2% |
| Total Assets | $778.13 Million |
| Market Capitalization | $497.46 Million USD |
Valuation Analysis
Below Book Valuation: The market values Zur Rose Group AG's assets below their book value (0.64 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Zur Rose Group AG's assets decreased by 10.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Zur Rose Group AG (2009–2024)
The table below shows the annual total assets of Zur Rose Group AG from 2009 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $778.13 Million | -10.19% |
| 2023-12-31 | $866.42 Million | -21.19% |
| 2022-12-31 | $1.10 Billion | -13.38% |
| 2021-12-31 | $1.27 Billion | -0.72% |
| 2020-12-31 | $1.28 Billion | +28.91% |
| 2019-12-31 | $991.73 Million | +36.50% |
| 2018-12-31 | $726.52 Million | +59.06% |
| 2017-12-31 | $456.76 Million | +74.65% |
| 2016-12-31 | $261.53 Million | +12.04% |
| 2015-12-31 | $233.42 Million | +2.33% |
| 2014-12-31 | $228.12 Million | +1.33% |
| 2013-12-31 | $225.11 Million | -15.32% |
| 2012-12-31 | $265.82 Million | +84.00% |
| 2011-12-31 | $144.47 Million | -0.55% |
| 2010-12-31 | $145.27 Million | -13.72% |
| 2009-12-31 | $168.37 Million | -- |